foxo4-dri senolytic 2024 study 2023 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Senotherapy for chronic lung disease – Peptide inhibitors targeting FOXO4-p53 interactions
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
























